APYX stock · TECH stock

APYX vs TECH

Apyx Medical Inc (APYX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.

Apyx Medical Inc (APYX) is a medical devices company listed on US.

Bio-Techne Corp (TECH) is a biotechnology company listed on US.

Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.

Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

APYX currently screens at market cap $179.6M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

Not investment advice. Open the APYX and TECH stock pages for the full models.

Not investment advice.

Popular Stock Comparisons